chiesi造句
- Established in 1935, Chiesi concentrates primarily on developing skeletal conditions.
- Chiesi : http : / / www . chiesigroup . com
- But Chiesi has not developed this form of medication.
- The study was funded by Chiesi Pharmaceuticals Inc ., an Italian maker of ipriflavone.
- The company's Paolo Chiesi did not return telephoned and faxed requests for comment Monday.
- Chiesi, 50, might never hug Ashton outside the prison; her release date is 2045.
- Proper identification of the battle was left to historians of the 20th century ( Chiesi 1979 ).
- Chiesi has allegedly exploited legislation that was created to compensate companies that have had substantial expenses with developing new drugs.
- Chiesi said saying goodbye is easier for her than some of the mothers because she sees Ashton more than once a year.
- In 2014 Chiesi was granted a monopoly on producing and marketing a form of medicine that helps prematurely-born infants breathe.
- It's difficult to see chiesi in a sentence. 用chiesi造句挺难的
- As well as developing drugs in-house, Chiesi has a policy of developing drugs in collaboration with pharmaceutical businesses outside Italy.
- Following the acquisition, in 1999, of Huddersfield based Trinity Pharmaceuticals, Chiesi has also had a significant presence in the United Kingdom.
- Chiesi does not want to disclose why they have raised their prices even though they have not had any expenses with developing this drug.
- Chiesi has a ten-year monopoly on caffeine citrate drugs on the European market and due to this monopoly they can keep competition out.
- Its executive producer is Claudia Chiesi, its producer is Thor Halvorssen, Constance Haqq is Co-Producer and Salvador Longoria and Tico Pujals are Associate Producers.
- "We're disappointed that the Shakespearean history programs cannot be built at the home site, " college President Claudia Chiesi said after the auction.
- Once-daily formulations with marketing authorisation include Advagraf ( Astellas Pharma ) and Envarsus ( marketed as Envarsus XR in US by Veloxis Pharmaceuticals and marketed in Europe by Chiesi ).
- It was developed by uniQure biopharma B . V . and is marketed in Europe and in other specific countries by Chiesi Farmaceutici S . p . A . since April 2013.
- "It makes you feel like a human being, " said Linda Chiesi, a convicted murderer who weeps as she talks about spending time with her 7-year-old grandson.
- 2010 was the year in which turnover broke through the Billion Euro barrier, with Chiesi recording sales growth of 16.4 % over the figure for 2009 . By 2013 turnover had reach Italian home market.